Phase II trial of vinorelbine in 120-hours continuous infusion in metastatic breast cancer refractory to anthracyclines

被引：0
|
作者：
Jara, C
Alonso, C
Fernandez, A
GomezAldaravi, L
Arroyo, M
Bosch, C
Tres, A
Gonzalez, M
机构：
[1] HOSP LA PAZ,MADRID,SPAIN
[2] HOSP CLIN,ZARAGOZA,SPAIN
[3] GEN HOSP,SECC ONCOL MED,ALBACETE,SPAIN
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [1] Phase II trial of paclitaxel and cisplatin in metastatic breast cancer refractory to anthracyclines
    Firvida-Perez, J
    Garcia-Mata, J
    Salgado, M
    Montanos, M
    Rodriguez, R
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 759 - 763
  • [2] PHASE I/II TRIAL OF CONTINUOUS-INFUSION VINORELBINE FOR ADVANCED BREAST-CANCER
    TOUSSAINT, C
    IZZO, J
    SPIELMANN, M
    MERLE, S
    MAYLEVIN, F
    ARMAND, JP
    LACOMBE, D
    TURSZ, T
    SUNDERLAND, M
    CHABOT, GG
    CVITKOVIC, E
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) : 2102 - 2112
  • [3] Phase II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer (MBC)
    Luu, T.
    Frankel, P.
    Chung, C.
    Mortimer, J.
    Hurria, A.
    Somlo, G.
    CANCER RESEARCH, 2010, 70
  • [4] Phase I/II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer
    Luu, Thehang
    Frankel, Paul
    Chung, Cathie
    Chow, Warren
    Mortimer, Joanne
    Hurria, Arti
    Somlo, George
    CLINICAL BREAST CANCER, 2014, 14 (02) : 94 - 100
  • [5] A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Estevez, Laura G.
    Batista, Norberto
    Sanchez-Rovira, Pedro
    Velasco, Amalia
    Provencio, Mariano
    Leon, Ana
    Domine, Manuel
    Cruz, Josefina
    Rodriguez, Milva
    CLINICAL BREAST CANCER, 2008, 8 (02) : 149 - 154
  • [6] A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines
    Vici, Patrizia
    Di Lauro, Luigi
    Sergi, Domenico
    Foggi, Paolo
    Viola, Giuditta
    Mottolese, Marcella
    Giotta, Francesco
    Fattoruso, Silvia I. S.
    Corsetti, Serena
    Giannarelli, Diana
    Botti, Claudio
    Lopez, Massimo
    ONCOLOGY, 2008, 75 (3-4) : 175 - 181
  • [7] A PHASE-II TRIAL OF VINORELBINE AND THIOTEPA IN METASTATIC BREAST-CANCER
    FABI, A
    TONACHELLA, R
    SAVARESE, A
    CIRULLI, S
    TOMAO, S
    CONTE, E
    COGNETTI, F
    ANNALS OF ONCOLOGY, 1995, 6 (02) : 187 - 189
  • [8] Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients:: A phase II study
    Nolè, F
    Munzone, E
    Mandalà, M
    Catania, C
    Orlando, L
    Zampino, MG
    Minchella, I
    Colleoni, M
    Peruzzotti, G
    Marrocco, E
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2001, 12 (01) : 95 - 100
  • [9] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Orphanos, George
    Alexopoulos, Athanasios
    Malliou, Savvoula
    Ioannidis, George
    Ardavanis, Alexandros
    Kandylis, Constantinos
    Stavrakakis, John
    Rigatos, Gerassimos
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (01) : 115 - 121
  • [10] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    George Orphanos
    Athanasios Alexopoulos
    Savvoula Malliou
    George Ioannidis
    Alexandros Ardavanis
    Constantinos Kandylis
    John Stavrakakis
    Gerassimos Rigatos
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 115 - 121
12345